The Saudi Food and Drug Authority (SFDA) introduced a new code of ethics for the marketing of pharmaceutical products. This new code aims at making all pharmaceutical practices subject to ethical and moral values. All pharmaceutical entities are required to abide by this code entirely in order to create an environment of fair competition between pharmaceutical organizations. Furthermore, pharmaceutical marketing on ethical basis improves the health sector and encourages all drug companies and manufacturers to provide true and unbiased information according to the standards of the code of ethics.

Should you have any specific inquiries regarding the subject matter, please contact us at